Recruiting
Phase 3

Selumetinib vs. Carboplatin

Sponsor:

National Cancer Institute (NCI)

Code:

NCT04166409

Conditions

Low Grade Astrocytoma

Low Grade Glioma

Metastatic Low Grade Astrocytoma

Metastatic Low Grade Glioma

Eligibility Criteria

Sex: All

Age: 2 - 21

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Carboplatin

Magnetic Resonance Imaging

Quality-of-Life Assessment

Questionnaire Administration

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-16. This information was provided to ClinicalTrials.gov by National Cancer Institute (NCI) on 2025-05-18.